26 Year Old Woman's Ovarian Cyst Raises Cancer Warning Signal

Author: Unknown. Reviewer: Unknown. Curator: Unknown. Production/Organizational Information: Wangwang Hospital, Hunan. Title: 26 Year Old Woman's Ovarian Cyst Raises Cancer Warning Signal. Introduction: Ovarian cancer is a hidden danger for women. A young woman learns of her risks during a check-up, highlighting early warning signs and screenings. Keywords: ['Ovarian cancer', 'Tumor markers', 'Early screening'].

A 26-year-old woman is a lively and cheerful office clerk. She usually has a regular lifestyle, maintains normal menstrual cycles, and has never experienced any discomfort. However, during a recent medical examination at Wangwang Hospital in Hunan, an ultrasound report revealed a liquid dark area measuring approximately 69 × 46 mm in the left adnexa.

Imaging diagnosis indicates a liquid dark area in the left adnexal region, the nature of which is yet to be determined, with a possible diagnosis of a chocolate cyst. Blood tests for tumor markers CA-125, CA-199, and CA-724 revealed elevated levels.

Upon receiving these results, the young woman quickly visited the gynecology outpatient clinic for a consultation. The doctor recommended hospitalization for surgery. During the procedure, a rapid biopsy was conducted, and results suggested the possibility of stage IA low-grade serous ovarian cancer.

After thorough discussion with the patient, the physician performed a comprehensive staged surgery aimed at preserving fertility. The postoperative pathology report confirmed: low-grade serous ovarian cancer stage IA (T1aN0M0). The patient is undergoing close follow-up, with examinations scheduled every three months. One year after surgery, she has recovered well, maintaining regular menstrual cycles, and continues to be monitored closely.

Ovarian cancer is often called the 'king of gynecological cancers,' and its danger lies in the fact that there are often no typical symptoms in the early stages. By the time 70% of patients are diagnosed, the disease is usually at an advanced stage, which significantly reduces survival rates. However, advancements in medical technology allow for early screening and risk warnings, which can effectively mitigate the risks at the onset.

Ovarian cancer is also referred to as the 'silent killer' because the ovaries are located deep within the pelvis, surrounded by intestines, ligaments, and other tissues. Unlike breast and uterine cancers, which can have symptoms more easily detected, ovarian cancer often presents with little to no typical symptoms in its early stages. The disease is insidious, with early-stage tumors being small and not causing pressure on surrounding organs, making them hard to detect.

Many women may confuse slight discomfort with ordinary gastrointestinal issues, causing them to miss crucial intervention opportunities. If you experience the following abnormalities for more than two weeks, it is important to take them seriously:

1. Persistent abdominal bloating, mild abdominal pain, or a sensation of heaviness.

2. Decreased appetite, feeling full quickly, and unexplained indigestion.

3. Unexplained increase in abdominal circumference and frequent, urgent need to urinate.

4. Menstrual irregularities and abnormal bleeding after menopause.

5. Unexplained fatigue and unexpected weight loss.

While these symptoms are non-specific, their persistence is a key indicator. If regular adjustments do not alleviate them, a specialized gynecological examination should be pursued immediately.

For both average women and high-risk groups, transvaginal ultrasound combined with tumor marker testing remains the primary screening option, providing high cost-effectiveness and solid clinical acceptance.

Transvaginal ultrasound is the preferred imaging method for ovarian cancer screening. It is non-invasive and radiation-free, effectively revealing the size, shape, cystic and solid structures of the ovaries, as well as blood flow signals. Its sensitivity for detecting small lesions over 1 cm exceeds 90%, making it a fundamental tool for identifying ovarian abnormalities.

2. Combined testing of tumor markers results in improved accuracy.

CA125 (Cancer Antigen 125) is a traditional marker sensitive to epithelial ovarian cancer but can be influenced by inflammation and menstrual cycles.

HE4 (Human Epididymis Protein 4) has higher specificity and is not affected by benign lesions.

The ROMA index (Risk of Ovarian Malignancy Algorithm), calculated using CA125, HE4, and menopausal status, significantly enhances the ability to distinguish between benign and malignant tumors, with early detection rates exceeding 85%.

The golden combination for screening involves transvaginal ultrasound, CA125, HE4, and the ROMA index, making it suitable for routine screening and initial evaluation of suspicious cases.

3. Genetic Testing for high-risk populations is crucial, involving the detection of mutations in BRCA1/2 (breast cancer susceptibility genes 1 and 2) and genes linked to Lynch syndrome. Carriers of these mutations face a heightened risk of developing ovarian cancer and should begin intensive screenings at earlier ages.

1. Healthy eating habits: Maintaining a light and balanced diet, reducing high-fat, fried, and processed foods while increasing the intake of vegetables, fruits, whole grains, and legumes can significantly lower risks over time. Sustaining a healthy weight and preventing obesity are crucial, as obesity has been shown to increase the risk of endometrial and ovarian cancers.

2. Avoid smoking and limit alcohol consumption: Smoking is correlated with a higher risk of ovarian cancer, and alcohol is a recognized risk factor for gynecological tumors.

3. Mental health: The fast pace of modern life can place significant pressure on young individuals, leading to psychological imbalance. Prolonged periods of late night activities can diminish physical resistance over time, leading to health issues. Maintaining a regular lifestyle, focusing on stress relief, engaging in appropriate exercise, and nurturing stable and positive emotions can help reduce the risk of tumor development.

(Editing 92)